Angelman syndrome resulting from UBE3A mutations in 14 patients from eight families: clinical manifestations and genetic counselling - PubMed (original) (raw)
Angelman syndrome resulting from UBE3A mutations in 14 patients from eight families: clinical manifestations and genetic counselling
A Moncla et al. J Med Genet. 1999 Jul.
Abstract
Angelman syndrome (AS) is a neurological disorder with a heterogeneous genetic aetiology. It most frequently results from a de novo interstitial deletion in the 15q11-q13 region, but in a few cases it is caused by paternal uniparental disomy (UPD) or an imprinting mutation. The remaining 20 to 30% of AS patients exhibit biparental inheritance and a normal pattern of allelic methylation in the 15q11-q13 region. In this latter group, mutations in the UBE3A gene have recently been shown to be a cause of AS. Here we describe the phenotypic expression in 14 AS cases involving eight UBE3A mutations. These comprise 11 familial cases from five families and three sporadic cases. Subtle differences from the typical phenotype of AS were found. Consistent manifestations were psychomotor delay, a happy disposition, a hyperexcitable personality, EEG abnormalities, and mental retardation with severe speech impairment. The other main manifestations of AS, ataxia, epilepsy, and microcephaly, were either milder or absent in various combinations among the patients. In addition, myoclonus of cortical origin was frequently observed with severe fits inducing myoclonic seizures. The majority of the patients were overweight. This study showed that ataxia, myoclonus, EEG abnormalities, speech impairment, characteristic behavioural phenotype, and abnormal head circumference are attributable to a deficiency in the maternally inherited UBE3A allele. Furthermore, analysis of mutation transmission showed an unexpectedly high rate of somatic mosaicism in normal carriers. These data have important consequences for genetic counselling.
Similar articles
- Distinct phenotypes distinguish the molecular classes of Angelman syndrome.
Lossie AC, Whitney MM, Amidon D, Dong HJ, Chen P, Theriaque D, Hutson A, Nicholls RD, Zori RT, Williams CA, Driscoll DJ. Lossie AC, et al. J Med Genet. 2001 Dec;38(12):834-45. doi: 10.1136/jmg.38.12.834. J Med Genet. 2001. PMID: 11748306 Free PMC article. - Mutation analysis of UBE3A in Angelman syndrome patients.
Malzac P, Webber H, Moncla A, Graham JM, Kukolich M, Williams C, Pagon RA, Ramsdell LA, Kishino T, Wagstaff J. Malzac P, et al. Am J Hum Genet. 1998 Jun;62(6):1353-60. doi: 10.1086/301877. Am J Hum Genet. 1998. PMID: 9585605 Free PMC article. - The spectrum of mutations in UBE3A causing Angelman syndrome.
Fang P, Lev-Lehman E, Tsai TF, Matsuura T, Benton CS, Sutcliffe JS, Christian SL, Kubota T, Halley DJ, Meijers-Heijboer H, Langlois S, Graham JM Jr, Beuten J, Willems PJ, Ledbetter DH, Beaudet AL. Fang P, et al. Hum Mol Genet. 1999 Jan;8(1):129-35. doi: 10.1093/hmg/8.1.129. Hum Mol Genet. 1999. PMID: 9887341 - Angelman syndrome: a review of the clinical and genetic aspects.
Clayton-Smith J, Laan L. Clayton-Smith J, et al. J Med Genet. 2003 Feb;40(2):87-95. doi: 10.1136/jmg.40.2.87. J Med Genet. 2003. PMID: 12566516 Free PMC article. Review. - Angelman syndrome: etiology, clinical features, diagnosis, and management of symptoms.
Guerrini R, Carrozzo R, Rinaldi R, Bonanni P. Guerrini R, et al. Paediatr Drugs. 2003;5(10):647-61. doi: 10.2165/00148581-200305100-00001. Paediatr Drugs. 2003. PMID: 14510623 Review.
Cited by
- Genetic investigation of the ubiquitin-protein ligase E3A gene as putative target in Angelman syndrome.
Manoubi W, Mahdouani M, Hmida D, Kdissa A, Rouissi A, Turki I, Gueddiche N, Soyah N, Saad A, Bouwkamp C, Elgersma Y, Mougou-Zerelli S, Gribaa M. Manoubi W, et al. World J Clin Cases. 2024 Jan 26;12(3):503-516. doi: 10.12998/wjcc.v12.i3.503. World J Clin Cases. 2024. PMID: 38322471 Free PMC article. - Genotype-Phenotype Correlations in Angelman Syndrome.
Yang L, Shu X, Mao S, Wang Y, Du X, Zou C. Yang L, et al. Genes (Basel). 2021 Jun 28;12(7):987. doi: 10.3390/genes12070987. Genes (Basel). 2021. PMID: 34203304 Free PMC article. Review. - Clinical aspects of a large group of adults with Angelman syndrome.
den Besten I, de Jong RF, Geerts-Haages A, Bruggenwirth HT, Koopmans M; ENCORE Expertise Center for AS 18+; Brooks A, Elgersma Y, Festen DAM, Valstar MJ. den Besten I, et al. Am J Med Genet A. 2021 Jan;185(1):168-181. doi: 10.1002/ajmg.a.61940. Epub 2020 Oct 27. Am J Med Genet A. 2021. PMID: 33108066 Free PMC article. - Angelman syndrome and melatonin: What can they teach us about sleep regulation.
Buonfiglio D, Hummer DL, Armstrong A, Christopher Ehlen J, DeBruyne JP. Buonfiglio D, et al. J Pineal Res. 2020 Nov;69(4):e12697. doi: 10.1111/jpi.12697. Epub 2020 Oct 11. J Pineal Res. 2020. PMID: 32976638 Free PMC article. Review. - UBE3A and Its Link With Autism.
Vatsa N, Jana NR. Vatsa N, et al. Front Mol Neurosci. 2018 Dec 4;11:448. doi: 10.3389/fnmol.2018.00448. eCollection 2018. Front Mol Neurosci. 2018. PMID: 30568575 Free PMC article. Review.
References
- Am J Hum Genet. 1993 Jul;53(1):105-12 - PubMed
- Am J Med Genet. 1993 Apr 1;46(1):12-5 - PubMed
- Am J Med Genet. 1994 Aug 15;52(2):158-63 - PubMed
- Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2563-7 - PubMed
- Am J Med Genet. 1995 Mar 27;56(2):176-83 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials